NCT01689571 A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics Status COMPLETED Phase PHASE2
NCT01688986 Environmental Polymorphisms Registry Health and Exposures Survey Status COMPLETED Phase N/A
NCT01687296 Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma Status COMPLETED Phase PHASE3
NCT01687283 Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma Status COMPLETED Phase PHASE3
NCT01686633 An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma. Status COMPLETED Phase PHASE3
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel Status COMPLETED Phase N/A
NCT01676987 Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT01675921 Implementation of ACT Through Facebook for Teenagers With Asthma Status COMPLETED Phase NA
NCT01669070 A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI) Status COMPLETED Phase PHASE1
NCT01668121 Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers Status COMPLETED Phase PHASE1
NCT01662778 The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma Status COMPLETED Phase PHASE4
NCT01659931 Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions Status COMPLETED Phase EARLY_PHASE1
NCT01659918 Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions Status COMPLETED Phase EARLY_PHASE1
NCT01659905 Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions Status COMPLETED Phase EARLY_PHASE1